Pfizer, Moderna and BioNTech
11h
Hosted on MSNFDA puts clinical hold on BioNTech’s malaria vaccine trialThe FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.
The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC ...
Emerging tools enable more accurate antigen production and presentation using mRNA instead of protein. In recent years, mRNA technology has come into its own, most prominently in the field of vaccine ...
9h
Hosted on MSNHow the 3 New COVID Vaccines Change the Way You PayNow that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and ...
9d
Zacks.com on MSNVaccine Stocks Rise as Chinese Scientists Discover a New CoronavirusStocks of MRNA, PFE, NVAX and BNTX rose in anticipation that a new virus in China could trigger another pandemic.
Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with ...
It has been five years since the World Health Organisation (WHO) declared COVID-19 a pandemic in March 2020 a decision that ...
WHO warns of ‘concerning’ Covid trends ahead of winter Billions of Pfizer/BioNTech and Moderna ... the first vaccines to use the mRNA technology came out just three years ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results